UNSPSC 85444804: The diagnosis of antineoplastic drugs

In this classification, this covers the group of activities that yields a diagnosis of other antineoplastic drugs. Other antineoplastic drugs is listed In The World Health Organization's International Statistical Classification of Diseases and Related Health Problems (ICD-10) as a four-character category under code Y43.3.

UNSPSC 85444804, The diagnosis of antineoplastic drugs, is a Commodity code. The recent state and local opportunities tagged under this code show a significant mismatch with its nominal scope—the solicitations posted involve diagnostic imaging systems, special education contracted services, and temporary health professional staffing for clinical ancillary roles, none of which relate to antineoplastic drug diagnosis. The code exhibits little relevant recent activity in state and local procurement; the opportunities appear to reflect misclassification rather than genuine procurement under this taxonomy category.

The three posted solicitations—San Mateo Medical Center's PACS system implementation (RFP, due Oct 21, 2026), Birdville Independent School District's special education services (competitive sealed proposal, due Oct 21, 2026), and Santa Clara Health System's temporary health professional staffing pool (qualification vehicle, proposals due Oct 7, 2026)—represent healthcare and education purchasing but do not align with diagnostic or therapeutic antineoplastic drug procurement. Geographic activity spans California (San Mateo and Santa Clara counties) and Texas (Tarrant County), but this distribution reflects the broader health system and school district sourcing rather than activity specific to antineoplastic drug diagnosis. A business development professional evaluating this code should treat the current posting history as an unreliable signal of actual procurement demand and verify directly with state and local health agencies or oncology-focused purchasing consortia whether meaningful opportunities exist under the correct classification.